Multiple putative protein targets

The term 'Multiple putative protein targets' is a non-specific designation used in pharmacological databases and drug discovery to describe a scenario where a compound's therapeutic activity is attributed to interactions with several hypothesized, but not yet fully validated, protein molecules. This classification is frequently applied to complex substances, such as botanical extracts or traditional medicines, where the clinical effect may result from a broad polypharmacological profile across various enzymes, receptors, or ion channels (ChEMBL Database, 2024). In early-stage drug development, compounds identified through phenotypic screening are often assigned this label until target deconvolution studies can isolate and validate the specific proteins responsible for the observed biological effect (Nature Reviews Drug Discovery, 2011). Because it represents a collection of potential binders rather than a single molecular entity, it does not possess a unique biological function or a specific role in a localized disease pathway. The inherent uncertainty in this designation poses significant challenges for optimizing drug potency and selectivity, as well as for predicting safety risks associated with off-target effects (Expert Opinion on Drug Discovery, 2013). Consequently, this entry serves as a placeholder indicating that further molecular characterization is required to define the drug's precise mechanism of action.

Other names

Putative protein targetsUnspecified protein targetsMulti-target profileHypothesized protein binders

The mechanism of action involves polypharmacological interactions with several hypothesized protein targets, often without a single primary mediator of efficacy being identified (Nature Reviews Drug Discovery, 2011).